Key facts
- It has raised $64.8M; the latest was Mezzanine ($21.8M) in Sep 2025.
- Notable investors include Edison Partners, M7 Ace Neo, Nullam Dapidus, Primus Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for PurpleLab
- ·The full record, as it builds
Funding rounds
No funding rounds for PurpleLab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PurpleLab
Operator of a healthcare data and analytics platform intended to simplify and enhance the lifecycle of discoveries from clinical and claims data. The company's platform features on-demand access to customizable queries and reports templates to profile and rank providers based on their quantitative performance metrics and provides a marketplace for patients, employers, and insurance providers to search for healthcare professionals according to the required profile, enabling healthcare providers and life science organizations to model and measure episodes of care.
- Sector
- Healthcare
- HQ
- Wayne, PA, United States
- Founded
- 2015
- Employees
- 115
- Website
- purplelab.com/
- Ownership
- Privately Held (backing)
PurpleLab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PurpleLab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PurpleLab in its N-PORT filings yet. We sweep new filings monthly.